Steven C. Gilman, Director at Akebia Therapeutics, Inc. (AKBA), sold 9,134 shares at $12.08 ($110K) on 2020-06-08, disclosed to the SEC on 2020-06-09.
Open-market sale of $110k AKBA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.08 | 4,567 | $55K | 50.0% |
| 2 | $12.08 | 4,567 | $55K | 50.0% |
| Total | $12.08 avg | 9,134 | $110K | 100% |
| Filing → |
| VCEL | SELL | 2024-09-20 | $531K | — | Filing → |
| VCEL | SELL | 2024-09-05 | $243K | — | Filing → |
| AKBA | SELL | 2022-06-07 | $2K | — | Filing → |